Chronic fatigue in childhood cancer survivors is associated with lifestyle and psychosocial factors; a DCCSS LATER study

Autor: Penson, A., Walraven, I., Bronkhorst, E., Grootenhuis, M.A., Maurice-Stam, H., de Beijer, I., van der Heiden-van der Loo, M., Tissing, W.J.E., van der Pal, H.J.H., de Vries, A.C.H., Bresters, D., Ronckers, C.M., van den Heuvel-Eibrink, M.M., Neggers, S., Versluys, B.A.B., Louwerens, M., Pluijm, S.M.F., Blijlevens, N., van Dulmen-den Broeder, E., Kremer, L.C.M., Knoop, H., Loonen, J.

Publikováno v: In ESMO Open December 2023 8(6)

Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER)

Autor: Atteveld, Jenneke van, Winter, D.T.C. de, Pluimakers, V.G., Fiocco, M., Nievelstein, R.A., Hobbelink, M.G., Kremer, L.C.M., Grootenhuis, M.A., Maurice-Stam, H., Tissing, W.J.E., Vries, A.C.M. de, Loonen, J.J., Dulmen-den Broeder, E. van, Pal, H.J. van der, Pluijm, S.M.F., Heiden-van der Loo, M., Versluijs, A.B., Louwerens, M., Bresters, D., Santen, H.M. van, Hoefer, I., Berg, S.A. van den, Hartogh, J. den, Hoeijmakers, J.H.J., Neggers, S.J., Heuvel-Eibrink, M.M. van den

Publikováno v: The Lancet Healthy Longevity, 4, e155-e165
The Lancet Healthy Longevity, 4, E155-E165
Dutch LATER study group 2023, ' Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER) : a cross-sectional study ', The Lancet Healthy Longevity, vol. 4, no. 4, pp. e155-e165 . https://doi.org/10.1016/S2666-7568(23)00020-X
The Lancet Healthy Longevity, 4(4), e155-e165. Elsevier Ltd
The Lancet Healthy Longevity, 4, 4, pp. E155-E165
The Lancet Healthy Longevity, 4(4), e155-e165. Elsevier Ltd.
The Lancet Healthy Longevity, 4, 4, pp. e155-e165

Contains fulltext : 291552.pdf (Publisher’s version ) (Open Access) BACKGROUND: Childhood cancer survivors appear to be at increased risk of frailty and sarcopenia, but evidence on the occurrence of and high-risk groups for these aging phenotypes i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f86edaaf7a2273fb820637184a7baf
https://pure.eur.nl/en/publications/544143a6-4925-445e-a5e6-67cbb82a06f9

The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors

Autor: Kooijmans, E.C.M., Pal, H.J.H. van der, Pluijm, S.M.F., Loo, M.V.V. van der van der, Kremer, L.C.M., Bresters, D., Broeder, E.V. den, Heuvel-Eibrink, M.M. van den, Loonen, J.J., Louwerens, M., Neggers, S.J.C., Ronckers, C., Tissing, W.J.E., Vries, A.C.H. de, Kaspers, G.J.L., Veening, M.A., Bokenkamp, A., Dutch LATER Study Grp

Publikováno v: Dutch LATER study group 2022, ' The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors ', Kidney International, vol. 102, no. 5, pp. 1136-1146 . https://doi.org/10.1016/j.kint.2022.05.029
Kidney International, 102(5), 1136-1146. Nature Publishing Group
Kidney International, 102(5), 1136-1146. Elsevier Inc.
Kidney international, 102(5), 1136-1146. Nature Publishing Group
Kidney International, 102, 5, pp. 1136-1146
Kidney International, 102(5), 1136-1146. ELSEVIER SCIENCE INC
Kidney International, 102, 1136-1146

This investigation aimed to evaluate glomerular dysfunction among childhood cancer survivors in comparison with matched controls from the general population. In the Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis, a nationwide c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c76dd5e5c3e594de041e6b6648d9eb
https://hdl.handle.net/11370/7df0f19a-407c-4cc8-9f39-04e7e486b4ee

Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER): a cross- sectional study

Autor: Atteveld, J.E., Winter, D.T.C. de, Pluimakers, V.G., Fiocco, M., Nievelstein, R.A.J., Hobbelink, M.G.G., Kremer, L.C.M., Grootenhuis, M.A., Maurice-Stam, H., Tissing, W.J.E., Vries, A.C.H. de, Loonen, J.J., Broeder, E.V.D., Pal, H.H. van der, Pluijm, S.M.F., Loo, M.V.V., Versluijs, A.B., Louwerens, M., Bresters, D., Santen, H.M. van, Hoefer, I., denBerg, S.A.A. van, Hartogh, J. den, Hoeijmakers, J.H., Neggers, S.J.C.M.M., Heuvel-eibrink, M.M. van den, Dutch LATER study grp

Publikováno v: The Lancet Healthy Longevity, 4(4), E155-E165. ELSEVIER

Background Childhood cancer survivors appear to be at increased risk of frailty and sarcopenia, but evidence on the occurrence of and high-risk groups for these aging phenotypes is scarce, especially in European survivors. The aim of this cross-secti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b04aa0bbdbfd679f66397a4919c85696
https://hdl.handle.net/1887/3619437

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.